Survey closed. Last response 8PM Sunday, June 10.Survey Results...

Survey closed. Last response 8PM Sunday, June 10.

Survey Results follow:

23 Respondents

1. What is your share holding status? 22 responses, 1 skipped
Not holding, but held previously (22.7%, 5)
Never held ( 0%, 0)
Holder (77.3%, 17)

2. What is your trading sentiment? 23 responses, 0 skipped
Buy (34.8%, 8)
Sell ( 4.3%, 1)
Buy and sell as opportunities arise (43.5%, 10)
Undisclosed (17.4%, 4)

3. Do you believe Genetic Technologies management is steering the company on the right path? 23 responses, 0 skipped
Yes (95.7%, 22)
No ( 4.3%, 1)

4. How is the CEO performing? 23 responses, 0 skipped
Outstanding (21.7%, 5)
Doing OK, no real problems (43.5%, 10)
Undecided (21.7%, 5)
Could do better (13.0%, 3)

5. When will Genetic Technologies post it's next cash flow positive result for a 6 month period? 23 responses, 0 skipped
By June 30 2012 (21.7%, 5)
By December 31 2012 (39.1%, 9)
By June 30 2013 (26.1%, 6)
It won't be cash flow positive for a long time (13.0%, 3)

6. Is there enough communication from Genetic Technologies? 23 responses, 0 skipped
Yes (34.8%, 8)
No (65.2%, 15)

7. Is there enough information about Brevagen Sales Figures? 23 responses, 0 skipped
Yes (13.0%, 3)
No (87.0%, 20)

8. What is the ideal period that sales figures should be published? 23 responses, 0 skipped
Each month (26.1%, 6)
Bi-monthly (39.1%, 9)
Stick to existing report schedule (34.8%, 8)
I don't want to hear about Brevagen. (0.0%, 0)